TY - JOUR
T1 - Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs
T2 - Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis
AU - Peterson, L. A.
AU - Thomson, N. M.
AU - Crankshaw, D. L.
AU - Donaldson, E. E.
AU - Kenney, P. J.
PY - 2001/8/1
Y1 - 2001/8/1
N2 - The tobacco-specific nitrosamine, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone, is activated to lung DNA methylating and pyridyloxobutylating intermediates. It is likely that both pathways play a role in lung tumor initiation by this nitrosamine. Previous studies indicated that O6-methylguanine (O6-mG) persistence is critical for lung tumor formation in A/J mice. The model pyridyloxobutylating agent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKOAc), enhanced the tumorigenic activity of a model methylating agent, acetoxymethylmethylnitrosamine (AMMN), presumably by increasing O6-mG persistence in lung DNA. We have been testing the hypothesis that the pyridyloxobutylation pathway increases the mutagenic activity of the DNA methylation pathway by preventing the repair of O6-mG by O6-alkylguanine-DNA alkyltransferase (AGT). In this study, we report that NNKOAc depletes AGT in lungs but not livers of A/J mice. The consequences of AGT depletion by NNKOAc were then compared with those observed with a known AGT inhibitor, O6-benzylguanine (O6-bG). NNKOAc and O6-bG had similar effects on the levels of AMMN-derived O6-mG at 4 and 96 h postinjection. This increase in O6-mG levels correlated to increased lung tumor multiplicity in animals simultaneously treated with AMMN (0.75 or 1 μmol) and NNKOAc or O6-bG. Only NNKOAc significantly increased lung tumor multiplicity at doses of 0.25 or 0.5 μmol AMMN. The results from these studies indicate that the pyridyloxobutylating agent, NNKOAc, can influence the tumorigenic activity of methylating agents in two ways. At low AMMN doses, the increase in tumor multiplicity is dominated by the additive tumorigenic properties of AMMN and NNKOAc. At higher AMMN doses, NNKOAc appears to enhance the tumorigenic activity of AMMN through enhanced depletion of the repair protein, AGT, leading to increased O6-mG persistence. It is likely that similar interactions are important for the organospecific effects of 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone.
AB - The tobacco-specific nitrosamine, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone, is activated to lung DNA methylating and pyridyloxobutylating intermediates. It is likely that both pathways play a role in lung tumor initiation by this nitrosamine. Previous studies indicated that O6-methylguanine (O6-mG) persistence is critical for lung tumor formation in A/J mice. The model pyridyloxobutylating agent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKOAc), enhanced the tumorigenic activity of a model methylating agent, acetoxymethylmethylnitrosamine (AMMN), presumably by increasing O6-mG persistence in lung DNA. We have been testing the hypothesis that the pyridyloxobutylation pathway increases the mutagenic activity of the DNA methylation pathway by preventing the repair of O6-mG by O6-alkylguanine-DNA alkyltransferase (AGT). In this study, we report that NNKOAc depletes AGT in lungs but not livers of A/J mice. The consequences of AGT depletion by NNKOAc were then compared with those observed with a known AGT inhibitor, O6-benzylguanine (O6-bG). NNKOAc and O6-bG had similar effects on the levels of AMMN-derived O6-mG at 4 and 96 h postinjection. This increase in O6-mG levels correlated to increased lung tumor multiplicity in animals simultaneously treated with AMMN (0.75 or 1 μmol) and NNKOAc or O6-bG. Only NNKOAc significantly increased lung tumor multiplicity at doses of 0.25 or 0.5 μmol AMMN. The results from these studies indicate that the pyridyloxobutylating agent, NNKOAc, can influence the tumorigenic activity of methylating agents in two ways. At low AMMN doses, the increase in tumor multiplicity is dominated by the additive tumorigenic properties of AMMN and NNKOAc. At higher AMMN doses, NNKOAc appears to enhance the tumorigenic activity of AMMN through enhanced depletion of the repair protein, AGT, leading to increased O6-mG persistence. It is likely that similar interactions are important for the organospecific effects of 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone.
UR - http://www.scopus.com/inward/record.url?scp=0035422061&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035422061&partnerID=8YFLogxK
M3 - Article
C2 - 11479212
AN - SCOPUS:0035422061
SN - 0008-5472
VL - 61
SP - 5757
EP - 5763
JO - Cancer Research
JF - Cancer Research
IS - 15
ER -